跳至主要内容
临床试验/EUCTR2016-001401-16-NL
EUCTR2016-001401-16-NL进行中(未招募)1 期

The SUGAR-DIP trial: Oral medication strategy versus insulin for diabetes in pregnancy - SUGAR-DIP

niversity Medical Center Utrecht0 个研究点目标入组 810 人开始时间: 2016年11月23日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
810

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • In order to be eligible to participate in this study, a subject must meet all of the following criteria:
  • - Aged 18 years or over
  • - Singleton pregnancy
  • - Diagnosis of GDM as per national guidelines
  • - Indication for pharmacological treatment of GDM
  • - Gestational age between 16 and 34 weeks
  • - Ability to understand Dutch or English
  • - Ability to provide written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 810
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Patients who meet any of the following criteria will be excluded from the study:
  • - Known pre-existent type 1 or type 2 diabetes mellitus
  • - Severe medical or psychiatric comorbidities
  • - Serious liver disease or kidney failure, or any other condition with contraindications for the use of either metformin or glibenclamide
  • - Pregnancy with a fetus affected by major congenital birth defects and/or chromosomal abnormalities

研究者

相似试验